Ignite Creation Date:
2024-05-06 @ 6:18 PM
Last Modification Date:
2024-10-26 @ 2:45 PM
Study NCT ID:
NCT05619068
Status:
RECRUITING
Last Update Posted:
2022-12-21
First Post:
2022-11-05
Brief Title:
The Evolution and Prognosis of Moyamoya Disease
Sponsor:
Chinese PLA General Hospital
Organization:
Chinese PLA General Hospital
Study Overview
Official Title:
Imaging Investigation on the Evolution and Prognosis of Moyamoya Disease
Status:
RECRUITING
Status Verified Date:
2022-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate the evolution of imaging appearances and cognitive function of Moyamoya disease MMD and to establish a prognosis evaluation system based on imaging biomarkers in MMD The study may be helpful to optimize and improve the diagnosis and pretreatment assessment of MMD and provide an important theoretical supplement to the existing guidelines for the management of MMD
Detailed Description:
Moyamoya disease MMD is a chronic progressive cerebrovascular disease of unknown etiology It is characterized by chronic progressive stenosis or occlusion of bilateral internal carotid arteries and abnormal puff vessels at the base of the brain MMD is one of the important causes of cerebrovascular accident in young and middle-aged people which leads to about 22 of stroke With the development of neurosurgery revascularization can effectively reduce the risk of stroke and other cerebrovascular accidents by increasing cerebral perfusion Therefore this project is expected to improve the diagnosis and pretreatment assessment of MMD from the traditional level of symptomatology to the level of brain cognitive function through new imaging methods and clinical approaches The study of cognitive function changes in follow-up period or after revascularization which is of great scientific significance for understanding the plasticity of cognitive function under different cerebral perfusion conditions will also be conducted
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None